Samil Pharmaceutical Co.,Ltd
000520.KSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
165
Cost of Revenue
104
Gross Profit
61
Gross Margin
36.8%
Operating Income
0
Operating Margin
0.1%
Net Income
-4
Net Margin
-2.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
6
EBITDA Margin
3.9%
2023
12/31/2023
Revenue
147
Cost of Revenue
93
Gross Profit
54
Gross Margin
36.8%
Operating Income
5
Operating Margin
3.3%
Net Income
1
Net Margin
0.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
8
EBITDA Margin
5.3%
2022
12/31/2022
Revenue
135
Cost of Revenue
84
Gross Profit
51
Gross Margin
37.6%
Operating Income
3
Operating Margin
2.2%
Net Income
-0
Net Margin
-0.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
8
EBITDA Margin
5.7%
2021
12/31/2021
Revenue
101
Cost of Revenue
64
Gross Profit
37
Gross Margin
36.5%
Operating Income
0
Operating Margin
0.3%
Net Income
-4
Net Margin
-4.0%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
4.6%
2020
12/31/2020
Revenue
92
Cost of Revenue
55
Gross Profit
37
Gross Margin
39.9%
Operating Income
5
Operating Margin
5.3%
Net Income
1
Net Margin
1.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
8
EBITDA Margin
9.2%